Show results for
Refine by
Cancer Institute For A Test Services
17 services found
by:Source BioScience based inNottingham, UNITED KINGDOM
Source LDPath produces cutting-edge companion diagnostic predictive and prognostic testing for cancer and other diseases. Our unparalleled combination of expertise in histopathology, coupled with the latest molecular diagnostics, enables us to provide a unique service to support specialist ...
Manufactured by:Kailos Genetics, LLC. based inHuntsville, ALABAMA (USA)
Genetic variations screened in the Expedio Hereditary Cancer Screening Service are associated with an increased risk of developing breast, endocrine, gastrointestinal, genitourinary, gynecologic, hematologic, nervous system, soft tissue, bone, and/or skin ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and localize multiple types of cancer through a single blood draw, with a very ...
by:Acoustic Consultants Limited based inKeynsham, UNITED KINGDOM
We have considerable experience in providing noise and acoustic advice for healthcare facilities. We provide cost effective advice to address the requirements of Health Technical Memorandum 08-01 (HTM 08-01) and ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as self sampling (validations for ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. SUMMIT aims to further evaluate GRAIL’s blood ...
by:Clinisys, Inc. based inTucson, ARIZONA (USA)
Optimise your Anatomic Pathology processes. Our comprehensive Anatomic Pathology solution is relied upon by healthcare professionals to test, diagnose and treat millions of patients every day. Our fully scalable and interoperable solution increases the efficiency of both routine tasks and the most complex ...
by:xCures based inOakland, CALIFORNIA (USA)
xCures’ patient-centric focus ensures that advanced cancer patients continuously engage with the xCures platform. Patients and their treating physicians receive decision support and access to leading therapeutics and diagnostics in return for ongoing access to their electronic medical records throughout their cancer journey. This direct patient engagement yields continuous, prospective Real ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
by:Auspex Diagnostics based inWarren, NEW JERSEY (USA)
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about their tumor to determine the most suitable treatment plan. The test ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
Histology, tissue staining using the latest in automated staining platforms, and digital pathology services form the foundation of a strong anatomic pathology program. Anatomic Pathology at NeoGenomics offers in-house comprehensive diagnostic services, backed by highly trained professionals, to provide oncologists and pathologists the information they need to determine the best treatment strategy ...
Manufactured by:Data Driven Diagnostic Sciences (D3Sciences) based inTucson, ARIZONA (USA)
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and pathologists. Upon examining a patient, and assessing the indicators for the presence of the disease, the oncologist consults with the radiologist and the decision is made for the radiologist ...
Manufactured by:Fluxion Biosciences Inc based inAlameda, CALIFORNIA (USA)
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the data…it’s that ...
Manufactured by:Mesothelioma + Asbestos Awareness Center based inSyracuse, NEW YORK (USA)
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once experimental, and the hope is that new, even more effective ...
by:Burning Rock Biotech Limited based inGuangzhou, CHINA
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may differ from each other regarding the in vivo genetic variation. As a result, patients ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic ...
by:SoBran Inc. based inFairfax, VIRGINIA (USA)
Our scientific and technical experts assemble customized research programs with attention to your specific project requirements, timelines and budget. To support small animal preclinical toxicology and drug discovery, we offer an expanding range of services that meet GLP and non-GLP compliant in vivo research requirements. Program management is certified to the ISO 9001:2008 standard. ...